Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase III Trial of CUV1647 in Polymorphic Light Eruption (PLE)
This study is ongoing, but not recruiting participants.
Study NCT00472901   Information provided by Clinuvel Pharmaceuticals Limited
First Received: May 10, 2007   Last Updated: February 25, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Polymorphic Light Eruption (PLE)
Additional conditions recognized in this trial
Dermatitis, Contact
Exanthema
More general conditions related to this trial
Dermatitis
Skin Diseases
Skin Diseases, Eczematous
Interventions listed in this trial
Afamelanotide (CUV1647)
Placebo
Sponsors listed in this trial
Clinuvel Pharmaceuticals Limited


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services